Skip to main content

Articles

Page 4 of 15

  1. Young people experiencing homelessness have alarmingly high rates of alcohol and other drug (AOD) use, which is associated with sexual risk behaviors such as unprotected sex, trading sex, and sex with multiple...

    Authors: Joan S. Tucker, Elizabeth J. D’Amico, Eric R. Pedersen, Anthony Rodriguez and Rick Garvey
    Citation: Addiction Science & Clinical Practice 2020 15:26
  2. Opioid use disorders (OUDs) have devastating effects on individuals, families, and communities. While medication treatments for OUD save lives and are increasingly utilized, rates of treatment dropout are very...

    Authors: Karen Chan Osilla, Kirsten Becker, Liisa Ecola, Brian Hurley, Jennifer K. Manuel, Allison Ober, Susan M. Paddock and Katherine E. Watkins
    Citation: Addiction Science & Clinical Practice 2020 15:25
  3. Gaps in electronic health record (EHR) data collection and the paucity of standardized clinical data elements (CDEs) captured from electronic and digital data sources have impeded research efforts aimed at und...

    Authors: Arjun Venkatesh, Caitlin Malicki, Kathryn Hawk, Gail D’Onofrio, Jeremiah Kinsman and Andrew Taylor
    Citation: Addiction Science & Clinical Practice 2020 15:24
  4. A lack of culturally and linguistically appropriate smoking cessation intervention programs exist among Chinese-Canadian communities. Smoking cessation programs that are provided in Canadian mainstream culture...

    Authors: Iraj Poureslami, Jessica Shum, Niloufar Aran and Noah Tregobov
    Citation: Addiction Science & Clinical Practice 2020 15:23
  5. Internet-based treatment has emerged as a cost-effective option for reaching people who for different reasons are not reached by traditional treatment. Internet-based treatment for problematic alcohol use, spe...

    Authors: Veronica Ekström and Magnus Johansson
    Citation: Addiction Science & Clinical Practice 2020 15:22
  6. In response to the findings of the Lynch et al. study on the association of suicide mortality and substance use disorder, this commentary addresses the need for increased suicide assessment and screening for p...

    Authors: Virna Little and Mary Crawford James
    Citation: Addiction Science & Clinical Practice 2020 15:21
  7. The process by which state Medicaid programs develop their preferred drug lists, and determine which medications require prior authorization, is opaque to many clinicians. This process is a synthesis of cost a...

    Authors: Marcus A. Bachhuber
    Citation: Addiction Science & Clinical Practice 2020 15:20
  8. There is growing public health concern around the potential impact of the opioid crisis on efforts to eradicate HIV. This secondary analysis seeks to determine if those who report opioids as their primary prob...

    Authors: Lacey Critchley, Adam Carrico, Natalie Gukasyan, Petra Jacobs, Raul N. Mandler, Allan E. Rodriguez, Carlos del Rio, Lisa R. Metsch and Daniel J. Feaster
    Citation: Addiction Science & Clinical Practice 2020 15:19
  9. For persons with substance use disorders (SUDs), 12-step groups (TSGs) are the most available and used peer-based recovery resource, worldwide. However, disengagement is common, and attrition may partly be due...

    Authors: John-Kåre Vederhus, Magnhild Høie and Bente Birkeland
    Citation: Addiction Science & Clinical Practice 2020 15:18
  10. Smartphone applications (apps) designed to assist users to reduce hazardous and harmful alcohol consumption show potential as an inexpensive alternative to traditional brief intervention in primary care. The a...

    Authors: Stephanie Colbert, Louise Thornton and Robyn Richmond
    Citation: Addiction Science & Clinical Practice 2020 15:17
  11. Buprenorphine-naloxone is an evidence-based treatment for Opioid Use Disorder. However, despite its efficacy, nearly half of participants are unsuccessful in achieving stabilization (i.e., period of time follo...

    Authors: Kirsten J. Langdon, Susan Ramsey, Caroline Scherzer, Kate Carey, Megan L. Ranney and Josiah Rich
    Citation: Addiction Science & Clinical Practice 2020 15:16
  12. Persons with an opioid use disorder (OUD) who were incarcerated face many challenges to remaining abstinent; concomitantly, opioid-overdose is the leading cause of death among this population, with the initial...

    Authors: Sean M. Murphy, Philip J. Jeng, Sabrina A. Poole, Ali Jalali, Frank J. Vocci, Michael S. Gordon, George E. Woody and Daniel Polsky
    Citation: Addiction Science & Clinical Practice 2020 15:15
  13. Prior research suggests that substance use disorders (SUDs) are associated with risk of suicide mortality, but most previous work has been conducted among Veterans Health Administration patients. Few studies h...

    Authors: Frances L. Lynch, Edward L. Peterson, Christine Y. Lu, Yong Hu, Rebecca C. Rossom, Beth E. Waitzfelder, Ashli A. Owen-Smith, Samuel Hubley, Deepak Prabhakar, L. Keoki Williams, Arne Beck, Gregory E. Simon and Brian K. Ahmedani
    Citation: Addiction Science & Clinical Practice 2020 15:14
  14. Emerging data points to a potential heroin use epidemic in South Africa. Despite this, access to methadone maintenance therapy and other evidence-based treatment options remains negligible. We aimed to assess ...

    Authors: Andrew Scheibe, Shaun Shelly, Tara Gerardy, Zara von Homeyer, Andrea Schneider, Kalvanya Padayachee, Shalon Balaguru Naidoo, Klaas Mtshweni, Ayanda Matau, Harry Hausler and Monique Marks
    Citation: Addiction Science & Clinical Practice 2020 15:13
  15. Cigarette smoking is much more prevalent among young people experiencing homelessness than in the general population of adolescents and young adults. Although many young homeless smokers are motivated to quit,...

    Authors: Joan S. Tucker, Eric R. Pedersen, Sebastian Linnemayr, William G. Shadel, Maria DeYoreo and Rushil Zutshi
    Citation: Addiction Science & Clinical Practice 2020 15:11
  16. The aim of this study was to investigate the effects of a web-based treatment program with therapist guidance for adults and adolescents with regular cannabis use from the general population.

    Authors: Kristina Sinadinovic, Magnus Johansson, Ann-Sofie Johansson, Thomas Lundqvist, Philip Lindner and Ulric Hermansson
    Citation: Addiction Science & Clinical Practice 2020 15:9
  17. This special issue of Addiction Science & Clinical Practice, “Addiction treatment access and utilization among criminal justice involved populations”, presents a series of articles on substance use disorder tr...

    Authors: Andrea Finlay, Ingrid Binswanger and Christine Timko
    Citation: Addiction Science & Clinical Practice 2020 15:5
  18. Treatment completion is the greatest challenge for the treatment of substance use disorders (SUDs). A previous investigation showed that complementary horse-assisted therapy (cHAT) was associated with higher r...

    Authors: Francesca Gatti, Espen Walderhaug, Ann Kern-Godal, Jeanette Lysell and Espen Ajo Arnevik
    Citation: Addiction Science & Clinical Practice 2020 15:7
  19. Hookah smoking is an emerging global health issue, especially in Eastern Mediterranean region; and accordingly, women are at the center of this issue as they have a more positive attitude towards hookah smokin...

    Authors: Sakineh Dadipoor, Gerjo Kok, Ali Heyrani, Teamur Aghamolaei, Mohtasham Ghaffari and Amin Ghanbarnezhad
    Citation: Addiction Science & Clinical Practice 2020 15:6
  20. There is an urgent need for strategies to address the US epidemic of prescription opioid, heroin and fentanyl-related overdoses, misuse, addiction, and diversion. Evidence-based treatment such as medications f...

    Authors: Gavin B. Bart, Andrew Saxon, David A. Fiellin, Jennifer McNeely, John P. Muench, Christopher W. Shanahan, Kristen Huntley and Robert E. Gore-Langton
    Citation: Addiction Science & Clinical Practice 2020 15:4
  21. Urine drug monitoring for medications for opioid use disorder (MOUD) such as buprenorphine can help to support treatment adherence. The practice of introducing unconsumed medication directly into urine (known ...

    Authors: Jill S. Warrington, Kaitlyn Booth, Gregory S. Warrington and Samuel Francis-Fath
    Citation: Addiction Science & Clinical Practice 2020 15:3
  22. If Russia is to achieve the UNAIDS 90-90-90 HIV targets, better approaches to engage, effectively treat, and retain patients in care are needed. This paper describes the protocol of a randomized controlled tri...

    Authors: Natalia Gnatienko, Dmitry Lioznov, Anita Raj, Elena Blokhina, Sydney Rosen, Debbie M. Cheng, Karsten Lunze, Sally Bendiks, Ve Truong, Natalia Bushara, Olga Toussova, Emily Quinn, Evgeny Krupitsky and Jeffrey H. Samet
    Citation: Addiction Science & Clinical Practice 2020 15:1
  23. Group-Based Opioid Treatment (GBOT) has recently emerged as a mechanism for treating patients with opioid use disorder (OUD) in the outpatient setting. However, the more practical “how to” components of succes...

    Authors: Randi Sokol, Mark Albanese, Aaronson Chew, Jessica Early, Ellie Grossman, David Roll, Greg Sawin, Dominic J. Wu and Zev Schuman-Olivier
    Citation: Addiction Science & Clinical Practice 2019 14:47
  24. The integration of opioid use disorder (OUD) care and competencies in graduate medical education training is needed. Previous research shows improvements in knowledge, attitudes, and practices after exposure t...

    Authors: Jarratt D. Pytell, Megan E. Buresh and Ryan Graddy
    Citation: Addiction Science & Clinical Practice 2019 14:46
  25. It has been estimated that approximately 15% of people who are incarcerated in the US have histories of opioid use disorder. Relapse to opioid use after release from prison poses a serious risk of HIV infectio...

    Authors: Thomas R. Blue, Michael S. Gordon, Robert P. Schwartz, Kathryn Couvillion, Frank J. Vocci, Terrence T. Fitzgerald and Kevin E. O’Grady
    Citation: Addiction Science & Clinical Practice 2019 14:45
  26. Cannabis use has become increasingly common in the U.S. in recent years, with legalization for medical and recreational purposes expanding to more states. With this increase in use and access, providers should...

    Authors: Devan Kansagara, William C. Becker, Chelsea Ayers and Jeanette M. Tetrault
    Citation: Addiction Science & Clinical Practice 2019 14:42
  27. Internet interventions have been developed and tested for several psychiatric and somatic conditions. Few people with substance use disorders receive treatment and many drug users say that they would prefer ge...

    Authors: Veronica Ekström and Magnus Johansson
    Citation: Addiction Science & Clinical Practice 2019 14:44
  28. For people living with HIV/AIDS (PLWHA), alcohol consumption is associated with poor treatment outcomes and medication adherence. This pilot study examined the feasibility of using smartphones and mobile Bluet...

    Authors: Carolyn Lauckner, Erica Taylor, Darshti Patel and Alexis Whitmire
    Citation: Addiction Science & Clinical Practice 2019 14:43
  29. Dependence to prescription and over-the-counter (OTC) drugs represents an increasing public health and clinical problem both in England and internationally. However, relatively little is known about those affe...

    Authors: Heidi Coombes and Richard J. Cooper
    Citation: Addiction Science & Clinical Practice 2019 14:41
  30. For more than 30 years, drug consumption rooms (DCRs) have been implemented in Western countries. DCRs are supported by a large body of evidence about public safety and public health effectiveness. However, a ...

    Authors: Pierre Smith, Louis Favril, Dominique Delhauteur, Freya Vander Laenen and Pablo Nicaise
    Citation: Addiction Science & Clinical Practice 2019 14:40
  31. The TAPS Tool is a substance use screening and brief assessment instrument that was developed for use in primary care medical settings. It is one of the first screening instruments to provide rapid assessment ...

    Authors: Angéline Adam, Robert P. Schwartz, Li-Tzy Wu, Geetha Subramaniam, Eugene Laska, Gaurav Sharma, Saima Mili and Jennifer McNeely
    Citation: Addiction Science & Clinical Practice 2019 14:39
  32. Tobacco smoking is highest among population groups which are the most socially disadvantaged. Internet-based smoking cessation programs have been found to be effective, though rates of internet access are not ...

    Authors: Sam McCrabb, Laura Twyman, Kerrin Palazzi, Ashleigh Guillaumier, Christine Paul and Billie Bonevski
    Citation: Addiction Science & Clinical Practice 2019 14:38
  33. Few studies have documented patient attitudes and experiences with extended-release naltrexone (XR-NTX) opioid relapse prevention in criminal justice settings. This study assessed barriers and facilitators of ...

    Authors: Melissa Velasquez, Mara Flannery, Ryan Badolato, Alexandria Vittitow, Ryan D. McDonald, Babak Tofighi, Ann R. Garment, Jonathan Giftos and Joshua D. Lee
    Citation: Addiction Science & Clinical Practice 2019 14:37
  34. Youth involved in the juvenile justice system (YIJJ) have high rates of substance use problems; however, rates of YIJJ engagement in substance use services is low. Barriers to service engagement include lack o...

    Authors: Matthew C. Aalsma, Allyson L. Dir, Tamika C. B. Zapolski, Leslie A. Hulvershorn, Patrick O. Monahan, Lisa Saldana and Zachary W. Adams
    Citation: Addiction Science & Clinical Practice 2019 14:36
  35. The global rise in opioid-related harms has impacted the United States severely. Current efforts to manage the opioid crisis have prompted a re-evaluation of many of the existing roles in the healthcare system...

    Authors: Paxton Bach and Daniel Hartung
    Citation: Addiction Science & Clinical Practice 2019 14:30
  36. Tobacco use is a chronic relapsing disease, and remains the leading cause of preventable death in much of the world. Increasingly, tobacco use, chiefly cigarette smoking, is being framed as a chronic disease, ...

    Authors: Steven L. Bernstein and Benjamin A. Toll
    Citation: Addiction Science & Clinical Practice 2019 14:29
  37. Chronic pain and heavy drinking commonly co-occur and can influence the course of HIV. There have been no interventions designed to address both of these conditions among people living with HIV (PLWH), and non...

    Authors: Tibor P. Palfai, Jessica L. Taylor, Richard Saitz, Maya P. L. Kratzer, John D. Otis and Judith A. Bernstein
    Citation: Addiction Science & Clinical Practice 2019 14:35
  38. Buprenorphine is a critically important treatment for addressing the opioid epidemic, but there are virtually no studies of physicians’ job satisfaction with providing buprenorphine. Physicians’ job satisfacti...

    Authors: Hannah K. Knudsen, Randy Brown, Nora Jacobson, Julie Horst, Jee-Seon Kim, Elizabeth Collier, Sanford Starr, Lynn M. Madden, Eric Haram, Alexander Toy and Todd Molfenter
    Citation: Addiction Science & Clinical Practice 2019 14:34

    The Commentary to this article has been published in Addiction Science & Clinical Practice 2019 14:33

  39. This study protocol describes a proposed randomized controlled trial that builds upon a successful pilot intervention study to address problematic and dangerous drinking among young adult college students stud...

    Authors: Eric R. Pedersen, Elizabeth J. D’Amico, Joseph W. LaBrie, Coreen Farris, David J. Klein and Beth Ann Griffin
    Citation: Addiction Science & Clinical Practice 2019 14:32
  40. The study examined the association of the Affordable Care Act’s 2014 Medicaid expansion on the use of psychosocial services and pharmacotherapies for opioid use disorders among Oregon Medicaid recipients.

    Authors: Dennis McCarty, Yifan Gu, John W. McIlveen and Bonnie K. Lind
    Citation: Addiction Science & Clinical Practice 2019 14:31
  41. Treating severe emotional dysregulation and co-occurring substance misuse is challenging. Dialectical behaviour therapy (DBT) is a comprehensive and evidence-based treatment for borderline personality disorder...

    Authors: Daniel Flynn, Mary Joyce, Ailbhe Spillane, Conal Wrigley, Paul Corcoran, Aoife Hayes, Marian Flynn, David Wyse, Barry Corkery and Brid Mooney
    Citation: Addiction Science & Clinical Practice 2019 14:28
  42. The continued escalation of opioid use disorder (OUD) calls for heightened vigilance to implement evidence-based care across the US. Rural care providers and patients have limited resources, and a number of ba...

    Authors: Gerald Cochran, Evan S. Cole, Jack Warwick, Julie M. Donohue, Adam J. Gordon, Walid F. Gellad, Todd Bear, David Kelley, Ellen DiDomenico and Jan Pringle
    Citation: Addiction Science & Clinical Practice 2019 14:25
  43. Despite the high prevalence of alcohol use disorders (AUDs), in 2016, only 7.8% of individuals meeting diagnostic criteria received any type of AUD treatment. Developing options for treatment within primary ca...

    Authors: Hildi J. Hagedorn, Jennifer P. Wisdom, Heather Gerould, Erika Pinsker, Randall Brown, Michael Dawes, Eric Dieperink, Donald Hugh Myrick, Elizabeth M. Oliva, Todd H. Wagner and Alex H. S. Harris
    Citation: Addiction Science & Clinical Practice 2019 14:24
  44. North America is in the midst of an opioid overdose epidemic. Although take-home naloxone and other measures have been an effective strategy to reduce overdoses, many events are unwitnessed and mortality remai...

    Authors: Keith Ahamad, Huiru Dong, Cheyenne Johnson, Kanna Hyashi, Kora DeBeck, M. J. Milloy and Evan Wood
    Citation: Addiction Science & Clinical Practice 2019 14:23
  45. Alcohol consumption among Indigenous Australians can involve a stop-start pattern of drinking, with consumption well above recommended guidelines on each occasion. Such intermittent drinking patterns can make ...

    Authors: K. S. Kylie Lee, James H. Conigrave, Scott Wilson, Jimmy Perry, Sarah Callinan, Robin Room, Tanya N. Chikritzhs, Tim Slade, Noel Hayman, Geoffrey Leggat and Katherine M. Conigrave
    Citation: Addiction Science & Clinical Practice 2019 14:22
  46. HIV care providers often serve as the specialist and the primary care point-of-contact for persons living with HIV (PLWH) and unhealthy alcohol use. The purpose of the present qualitative study was to understa...

    Authors: Natalie E. Chichetto, Zachary L. Mannes, Megan K. Allen, Robert L. Cook and Nicole Ennis
    Citation: Addiction Science & Clinical Practice 2019 14:21

Affiliated with

Annual Journal Metrics

Archival content

Addiction Science & Clinical Practice was formerly published by NIDA and previous issues of the journal can be viewed here.